Ovarian cancer

You have access
Antitumour Effects of Intravenous Administration of BK-UM, a Novel Inhibitor of HB-EGF, in Ovarian Cancer Therapy
SATOSHI FUKAGAWA, FUSANORI YOTSUMOTO, TAKASHI ODAWARA, SADAO MANABE, TOYOKAZU ISHIKAWA, SHIN'ICHIRO YASUNAGA and SHINGO MIYAMOTO

Anticancer Research July 2017, 37 (7) 3891-3896;
You have access
Serum Heparin-binding Epidermal Growth Factor-like Growth Factor (HB-EGF) as a Biomarker for Primary Ovarian Cancer
KOHEI MIYATA, FUSANORI YOTSUMOTO, SATOSHI FUKAGAWA, CHIHIRO KIYOSHIMA, NAM SUNG OUK, DAICHI URUSHIYAMA, TOMOHIRO ITO, TAKAHIRO KATSUDA, MASAMITSU KURAKAZU, RYOTA ARAKI, AYAKO SANUI, DAISUKE MIYAHARA, MASAHARU MURATA, KYOKO SHIROTA, HIROSHI YAGI, TADAO TAKONO, KIYOKO KATO, NOBUO YAEGASHI, KOHEI AKAZAWA, MASAHIDE KUROKI, SHIN'ICHIRO YASUNAGA and SHINGO MIYAMOTO

Anticancer Research July 2017, 37 (7) 3955-3960;
You have access
Targeted Therapy in Ovarian Cancer. A Comprehensive Systematic Review of Literature
YASSER DIAB and MUSTAFA ZELAL MUALLEM

Anticancer Research June 2017, 37 (6) 2809-2815;
You have access
3,4’,7-O-trimethylquercetin Inhibits Invasion and Migration of Ovarian Cancer Cells
KOSEI YAMAUCHI, SYEDA H. AFROZE, TOHRU MITSUNAGA, TIMOTHY C. MCCORMICK, THOMAS J. KUEHL, DAVID C. ZAWIEJA and MOHAMMAD N. UDDIN

Anticancer Research June 2017, 37 (6) 2823-2829;
You have access
Protein Complex of Fibrinogen Gamma Chain and Complement Factor H in Ovarian Cancer Patient Plasma
KEN-ICHI HONDA, RYOKO ASADA, KATSUHIRO KAGEYAMA, TAKESHI FUKUDA, HIROYUKI TERADA, TOMOYO YASUI, TOSHIYUKI SUMI, MASAYASU KOYAMA, OSAMU ISHIKO and TADASHI SUGAWA

Anticancer Research June 2017, 37 (6) 2861-2866;
You have access
Primary Peritoneal Serous Carcinoma in Men: A Rare and Non-BRCA-associated Entity
SUSAN L. NEUHAUSEN, HAGIT SHANI, LITAL KEINAN BOKER, LINDA STEELE, BARBARA G. SILVERMAN, LAURA OTTINI, VALENTINA SILVESTRI, YAEL LAITMAN, JACOB KORACH, TAMAR PERRI and EITAN FRIEDMAN

Anticancer Research June 2017, 37 (6) 3069-3072;
You have access
Preoperative CA-125 Values as a Predictive Factor for the Postoperative Outcome in Primary Serous Ovarian Cancer
MUSTAFA ZELAL MUALLEM, ASYA PARASHKEVOVA, JUMANA ALMUHEIMID, ROLF RICHTER, YASSER DIAB, ELENA IOANA BRAICU and JALID SEHOULI

Anticancer Research June 2017, 37 (6) 3157-3161;
You have access
New and Old Genes Associated with Topotecan Resistance Development in Ovarian Cancer Cell Lines
ANDRZEJ KLEJEWSKI, MONIKA ŚWIERCZEWSKA, KATARZYNA ZAORSKA, MACIEJ BRĄZERT, MICHAŁ NOWICKI, MACIEJ ZABEL and RADOSŁAW JANUCHOWSKI

Anticancer Research April 2017, 37 (4) 1625-1636;
You have access
PI3K Catalytic Isoform Alteration Promotes the LIMK1-related Metastasis Through the PAK1 or ROCK1/2 Activation in Cigarette Smoke-exposed Ovarian Cancer Cells
GA BIN PARK and DAEJIN KIM

Anticancer Research April 2017, 37 (4) 1805-1818;
You have access
Synchronous Endometrial and Ovarian Cancer in Young Women: Case Report and Review of the Literature
ASKIN DOGAN, BEATE SCHULTHEIS, GÜNTHER A. REZNICZEK, ZIAD HILAL, CEM CETIN, GÜNTHER HÄUSLER and CLEMENS B. TEMPFER

Anticancer Research March 2017, 37 (3) 969-978;

Main menu

User menu

Search

Ovarian cancer

Pages